Pathos

AI breakthroughs in drug development.

📋 Overview of  Pathos

Founding Year

2022

Estimated Funding

$0000

Size

$0000

Locations

Chicago

Primary Industry

Biotechnology, Industry

📙 About  Pathos

Pathos is a clinical-stage biotechnology company dedicated to transforming drug development with AI technologies. It leverages oncology and genomic data to uncover novel biological insights and optimize patient selection, ensuring that innovative therapies reach patients. Partnering with biopharmaceutical companies helps revive shelved drug programs and accelerates biomarker-driven development paths.

💰 Recent Investors of  Pathos

Builders VC, Eric Lefkofsky, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.